SSR411298
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SSR411298, covering 2013-03-15 to 2013-03-21. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer Pain [Phase 2]